12190 Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than April 1, 2021. 

A. Federal Reserve Bank of Richmond 

(Adam M. Drimer, Assistant Vice 

President) 701 East Byrd Street, 

Richmond, Virginia 23219. Comments 

can also be sent electronically to or 

Comments.applications@rich.frb.org: 

1. National Capital Bancorp, Inc., 

Washington, DC; to become a bank 

holding company by acquiring The 

National Capital Bank of Washington, 

Washington, DC. 

Board of Governors of the Federal Reserve 

System, February 25, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–04302 Filed 3–1–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Improving Rural Health 

Through Telehealth-Guided Providerto-Provider Communication 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Improving Rural Health Through 

Telehealth-Guided Provider-to-Provider 

Communication, which is currently 

being conducted by the AHRQ’s 

Evidence-based Practice Centers (EPC) 

Program. Access to published and 

unpublished pertinent scientific 

information will improve the quality of 

this review. 

DATES: Submission Deadline on or 

before April 1, 2021. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers 

Lane, Mail Stop 06E77D, Rockville, 

MD 20857 

FOR FURTHER INFORMATION CONTACT: 

Jenae Benns, Telephone: 301–427–1496 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Improving Rural Health 

Through Telehealth-Guided Provider-toProvider Communication. AHRQ is 

conducting this systematic review 

pursuant to Section 902 of the Public 

Health Service Act, 42 U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Improving Rural Health 

Through Telehealth-Guided Provider-toProvider Communication, including 

those that describe adverse events. 

Telehealth for this review of providerto-provider communication is defined 

as any telecommunications facilitated 

interaction among, or support for, 

healthcare professionals designed to 

improve access, quality of care, or 

health outcomes for rural patients and 

populations. This includes a wide range 

of clinical applications such as remote 

ICU management; consultations for 

inpatient and outpatient care; and 

remote rounds or group education and 

case review (e.g., Project ECHO, etc.). 

The entire research protocol is available 

online at: https://

effectivehealthcare.ahrq.gov/products/ 

rural-telehealth/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Improving Rural Health 

Through Telehealth-Guided Provider-toProvider Communication helpful: 

D A list of completed studies that 

your organization has sponsored for this 

indication. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: Study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, and primary and secondary 

outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this indication and an 

index outlining the relevant information 

in each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 39 / Tuesday, March 2, 2021 / Notices 12191 

confidential; marketing materials; study 

types not included in the review; or 

information on indications not included 

in the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://

www.effectivehealthcare.ahrq.gov/ 

email-updates. 

The systematic review will answer the 

following questions. This information is 

provided as background. AHRQ is not 

requesting that the public provide 

answers to these questions. 

Key Questions (KQs) 

KQ 1. What is the effectiveness of 

provider-to-provider telehealth for rural 

patients? 

a. What is the impact of provider-toprovider telehealth on rural patient and 

population outcomes? 

b. What is the impact of provider-toprovider telehealth on healthcare 

providers? 

c. What is the impact of provider-toprovider telehealth on private and 

public (ex. CMS, TriCare, VA, etc.) 

payers? 

d. What adverse events or unintended 

consequences are associated with 

provider-to-provider telehealth for rural 

patients? 

e. What are the methodological 

weaknesses of the identified 

effectiveness studies of provider-toprovider telehealth for rural patients 

and what improvements in study design 

(e.g., focus on relevant comparisons and 

outcomes) might increase the impact of 

future research? 

KQ 2. What is the effectiveness of 

implementation strategies for providerto-provider telehealth in rural areas? 

a. What is the uptake of different 

types of provider-to-provider telehealth 

in rural areas? 

Æ Who are the current patients, 

providers, and payers engaged in 

provider-to-provider telehealth in rural 

areas? 

Æ What factors affect whether 

provider-to-provider telehealth in rural 

areas can be sustained? 

b. Which barriers and facilitators 

impact adoption and implementation of 

provider-to-provider telehealth in rural 

areas? 

c. Which strategies are effective in 

sustaining provider-to-provider 

telehealth in rural areas? 

d. What are the methodological 

weaknesses of the identified studies of 

implementation and sustainability of 

provider-to-provider telehealth in rural 

areas and what improvements in study 

design (e.g., focus on relevant 

comparisons and outcomes) might 

increase the impact of future research? 

Populations, Interventions, 

Comparators, Outcomes, Settings 

• Population(s) 

Æ Rural individual patients, patient 

families/care partners, and patient 

populations. 

Æ Healthcare providers (individuals 

and organizations) who provide health 

care services to rural patients or 

populations. 

• Providers include any profession or 

occupation providing formal, paid 

services. 

• Family or informal care partners are 

not considered providers. 

Æ Payers who pay for healthcare 

services for rural patients or 

populations. 

• Interventions 

Æ Provider-to-provider telehealth 

defined as: Any telecommunications 

facilitated interaction among, or support 

for, healthcare professionals designed to 

improve access, quality of care, or 

health outcomes for rural patients and 

populations. 

• Comparators 

Æ KQ1: Other telehealth facilitated 

care (not provider-to-provider), usual 

(in-person) provider-to-provider 

supports, no interaction or no care. 

Æ KQ2: Different strategies for 

dissemination, implementation, or 

spread; no strategies; time periods prior 

to implementation. 

• Outcomes 

Æ KQ1: Clinical outcomes for the 

identified conditions (patient-reported 

outcomes, mortality, morbidity, such as 

function, illness recovery, infection); 

Economic outcomes such as return on 

investment, cost, volume of visits, and 

resource use, including length of stay 

and readmissions; Intermediate 

Outcomes; Patient satisfaction, behavior 

(such as care-seeking and compliance), 

and decisions such as completion of 

treatment, or satisfaction with less travel 

to access healthcare; Provider 

satisfaction, behavior, and decisions 

such as choice of treatment or antibiotic 

stewardship; Access measures and 

indicators including but not limited to 

time to diagnosis or time to treatment. 

Æ KQ2: Indicators and measures of 

uptake (e.g., rates of use, timing to 

implementation) and characteristics of 

users; categories and descriptors of 

barriers and facilitators; categories and 

descriptors of strategies. 

• Settings 

Æ Outpatient (primary care and 

specialty care), inpatient, prehospital 

and emergency care, post-acute and 

long-term care. 

Æ Civilian, Veterans Administration, 

or military. 

Æ Health care and non-healthcare 

settings where health services are 

delivered including in the home. 

Æ U.S. relevant settings [Note that 

studies from countries with significantly 

different healthcare systems and fewer 

resources (e.g., low-income countries) 

are excluded.] 

Dated: February 24, 2021. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2021–04187 Filed 3–1–21; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10175] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 


jbell on DSKJLSW7X2PROD with NOTICES